Dividend HALEOS LABS LIMITED has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 1.50 per equity share. HALEOS LABS LIMITED has informed the Exchange that Board of Directors at its meeting held on May 29, 2026, recommended Final Dividend of Rs. 1.50 per equity share.
Company Update On 16.10.2025 the Hon''ble NCLT, Mumbai passed an order allowing the liquidation process of the company under Indian Bankruptcy Code 2016. Finalisation of accounts for the year ended 31.3.2026 (as per the liquidation) is under process and the same will be uploaded when ready. On 16.10.2025 the Hon''ble NCLT, Mumbai passed an order allowing the liquidation process of the company under Indian Bankruptcy Code 2016. Finalisation of accounts for the year ended 31.3.2026 (as per the
Company Update On 16.10.2025 the Hon''ble NCLT, Mumbai passed an order allowing the liquidation process of the company under Indian Bankruptcy Code 2016. Finalisation of accounts for the year ended 31.3.2026 (as per the liquidation) is under process and the same will be uploaded when ready. On 16.10.2025 the Hon''ble NCLT, Mumbai passed an order allowing the liquidation process of the company under Indian Bankruptcy Code 2016. Finalisation of accounts for the year ended 31.3.2026 (as per the
Company Update On 16.10.2025 the Hon''ble NCLT, Mumbai passed an order allowing the liquidation process of the company under Indian Bankruptcy Code 2016. Finalisation of accounts for the year ended 31.3.2026 (as per the liquidation) is under process and the same will be uploaded when ready. On 16.10.2025 the Hon''ble NCLT, Mumbai passed an order allowing the liquidation process of the company under Indian Bankruptcy Code 2016. Finalisation of accounts for the year ended 31.3.2026 (as per the
Corp. Action The Board approved and recommended the final dividend of 25% i.e. Rs. 2.5/- per equity share of Rs. 10/- each The Board approved and recommended the final dividend of 25% i.e. Rs. 2.5/- per equity share of Rs. 10/- each
Corp. Action The Board approved and recommended the final dividend of 25% i.e. Rs. 2.5/- per equity share of Rs. 10/- each The Board approved and recommended the final dividend of 25% i.e. Rs. 2.5/- per equity share of Rs. 10/- each
Investor Presentation Repro India Limited has informed the Exchange about Investor Presentation Repro India Limited has informed the Exchange about Investor Presentation
Investor Presentation Repro India Limited has informed the Exchange about Investor Presentation Repro India Limited has informed the Exchange about Investor Presentation
Investor Presentation Repro India Limited has informed the Exchange about Investor Presentation Repro India Limited has informed the Exchange about Investor Presentation
General Updates Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc.
General Updates Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc. Lupin Limited has informed the Exchange about update on acquisition of minority shareholding in Multicare Pharmaceuticals Philippines, Inc.
Corp Action Board of directors in its meeting held on May 29, 2026 has recommended dividend of Rs. 4 per equity shares of Rs. 10 each for the FY25-26 subject to the approval of the shareholders in the ensuing Annual General Meeting and the joint venture partner, Ushin Ltd. in terms of Joint Venture Agreement. Board of directors in its meeting held on May 29, 2026 has recommended dividend of Rs. 4 per equity shares of Rs. 10 each for the FY25-26 subject to the approval of the shareholders in th
NSE & BSE filings, earnings, insider trades, and smart volume alerts — on WhatsApp or Telegram. No separate app to install.